Liang Cheng

发表

UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancer

Y. Ling, Jian Huang, Qianghua Zhou, 2022, International journal of biological sciences.

GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis

T. Anthony, R. Wek, Emily T Mirek, 2022, bioRxiv.

Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care.

H. Kung, M. Tann, C. Bahler, 2022, Urologic oncology.

Recent Advances of Deep Learning for Computational Histopathology: Principles and Applications

Daoqiang Zhang, Kun Huang, J. Zhang, 2022, Cancers.

HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program

Tianxin Lin, W. Dong*, Jian Huang, 2022, Cancer communications.

Establishment of a prognostic model to predict chemotherapy response and identification of RAC3 as a chemotherapeutic target in bladder cancer

Tianxin Lin, Jian Huang, Jilin Wu, 2023, Environmental toxicology.

TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination

Tianxin Lin, Qiang Zhang, Hao Chen, 2023, Journal of Experimental & Clinical Cancer Research.

NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer.

Tianxin Lin, Qiang Zhang, Qianghua Zhou, 2023, Cancer research.

Crosstalk between bladder cancer and the tumor microenvironment: Molecular mechanisms and targeted therapy

Chenwei Yang, Liang Cheng, Xiaole Lu, 2024, The Innovation Medicine.